+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI in Cancer Diagnostics Market by Application (Diagnostic Imaging, Genomic Profiling, Pathology), Component (Hardware, Services, Software), End User, Cancer Type, Technology - Global Forecast 2025-2030- Product Image
AI in Cancer Diagnostics Market by Application (Diagnostic Imaging, Genomic Profiling, Pathology), Component (Hardware, Services, Software), End User, Cancer Type, Technology - Global Forecast 2025-2030- Product Image
Sale

AI in Cancer Diagnostics Market by Application (Diagnostic Imaging, Genomic Profiling, Pathology), Component (Hardware, Services, Software), End User, Cancer Type, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716125
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The AI in cancer diagnostics market is undergoing rapid evolution as artificial intelligence redefines detection, analysis, and treatment planning for oncology. Increasing adoption of AI algorithms across imaging, genomics, and pathology is enabling healthcare providers and technology leaders to deliver more precise, efficient solutions to meet rising clinical demands and operational challenges.

Market Snapshot: AI in Cancer Diagnostics Market

The AI in cancer diagnostics market grew from USD 266.28 million in 2024 to USD 326.78 million in 2025. It is expected to continue growing at a CAGR of 21.68%, reaching USD 864.46 million by 2030. This robust growth is driven by advances in deep learning, increased clinical acceptance, and expanding global investments in healthcare digitization. The market demonstrates sustained momentum due to the convergence of imaging, genomic, and digital pathology innovations, alongside regulatory progress and collaborative industry efforts across key geographies.

Scope & Segmentation

This report delivers a detailed view of the AI in cancer diagnostics market, covering major segments, regions, and enabling technologies shaping market opportunities:

  • Application Areas: Diagnostic imaging, genomic profiling, pathology, predictive analytics, and AI-driven treatment planning.
  • Components: Hardware platforms, managed and professional services, software solutions including cloud-based and on-premises deployments.
  • End Users: Diagnostic laboratories, hospitals and clinics, pharmaceutical companies, research institutes.
  • Cancer Types: Breast, colorectal, lung, and prostate cancers, each addressed with tailored algorithms and workflows.
  • Technology Types: Deep learning, machine learning, and natural language processing frameworks.
  • Geographical Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, UAE, South Africa, Turkey), and Asia-Pacific (China, India, Japan, Australia, South Korea, and key ASEAN countries).
  • Leading Industry Players: Siemens Healthineers, GE HealthCare Technologies, Koninklijke Philips N.V., Fujifilm Holdings, IBM, Roche Diagnostics, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Hologic.

Key Takeaways for AI in Cancer Diagnostics

  • AI integration is streamlining traditional cancer diagnostics by enabling faster data processing and supporting clinicians in complex decision-making.
  • Cross-disciplinary collaboration among technology developers, hospitals, and research institutions accelerates innovation, deployment, and validation of AI-powered tools.
  • Regulatory clarity around software as a medical device is helping foster adoption while addressing patient safety and clinical effectiveness.
  • Regional dynamics—including digitization initiatives in Asia-Pacific and pan-regional data governance in Europe, Middle East, and Africa—shape AI adoption rates and technology customization.
  • AI-driven platforms are being tailored for specific cancer types, enhancing the ability to stratify risk, interpret images, and optimize therapeutic planning based on multimodal data.
  • As cloud and on-premises deployment options expand, vendors are developing flexible solutions to suit organizational requirements for security, scalability, and compliance.

Tariff Impact: Navigating the 2025 United States Tariffs

The introduction of tariffs in the United States in 2025 has brought cost pressures to procurement of AI-enabled diagnostic equipment and consumables. Healthcare organizations and technology providers are adapting through localized manufacturing, alternative sourcing, and renegotiated contracts to preserve access and pricing. These shifts also accelerate joint ventures and regional alliances, contributing to greater supply chain resilience while encouraging innovation in operational models. Regulatory agencies and industry groups are closely evaluating the broader impact of these trade measures on affordability and ongoing technological advancement.

Methodology & Data Sources

This report utilizes a hybrid methodology that combines secondary research—drawing on peer-reviewed journals, industry publications, and regulatory guidance—with primary research via expert interviews across clinical and technology domains. Data have been validated through triangulation with real-world evidence and thematic trend analysis, ensuring objective and actionable market insights.

Why This Report Matters

  • Provides actionable intelligence for senior decision-makers seeking to deploy or invest in AI-driven cancer diagnostics solutions across global markets.
  • Aligns technology trends and regulatory shifts with opportunities for innovation, improved care delivery, and competitive strategy.
  • Supports informed business and investment decisions by offering granular segmentation, regional perspectives, and industry benchmarking.

Conclusion

AI technologies are reshaping cancer diagnostics, unlocking new pathways for clinical precision and operational efficiency. Organizations that embrace data-driven strategies and regulatory alignment will be positioned to lead in the advancing oncology landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multi-omics data with AI to refine personalized oncology treatment pathways
5.2. Development of explainable AI models to increase clinician trust in automated cancer diagnostics
5.3. Emergence of federated learning frameworks protecting patient data in cross-institutional AI research
5.4. Adoption of AI-driven liquid biopsy analysis for non-invasive early detection of circulating tumor DNA
5.5. Use of natural language processing to extract actionable insights from unstructured pathology reports
5.6. Advancements in real-time AI-based histopathology image analysis during surgical oncology procedures
5.7. Regulatory approvals accelerating commercialization of AI-enabled cancer diagnostic platforms globally
5.8. Implementation of edge computing solutions for point-of-care AI-assisted cancer screening in underserved areas
5.9. Incorporation of AI predictive analytics to stratify patient risk based on electronic health record patterns
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI in Cancer Diagnostics Market, by Application
8.1. Introduction
8.2. Diagnostic Imaging
8.2.1. CT Imaging
8.2.2. MRI Imaging
8.2.3. PET Imaging
8.2.4. Ultrasound Imaging
8.3. Genomic Profiling
8.3.1. DNA Sequencing
8.3.2. Epigenetic Analysis
8.3.3. RNA Sequencing
8.4. Pathology
8.4.1. Digital Pathology
8.4.2. Histopathology
8.5. Predictive Analytics
8.5.1. Outcome Prediction
8.5.2. Risk Assessment
8.6. Treatment Planning
8.6.1. Radiotherapy Planning
8.6.2. Surgical Planning
9. AI in Cancer Diagnostics Market, by Component
9.1. Introduction
9.2. Hardware
9.3. Services
9.3.1. Managed Services
9.3.2. Professional Services
9.4. Software
9.4.1. Cloud Based
9.4.2. On Premises
10. AI in Cancer Diagnostics Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals And Clinics
10.4. Pharmaceutical Companies
10.5. Research Institutes
11. AI in Cancer Diagnostics Market, by Cancer Type
11.1. Introduction
11.2. Breast Cancer
11.3. Colorectal Cancer
11.4. Lung Cancer
11.5. Prostate Cancer
12. AI in Cancer Diagnostics Market, by Technology
12.1. Introduction
12.2. Deep Learning
12.3. Machine Learning
12.4. Natural Language Processing
13. Americas AI in Cancer Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa AI in Cancer Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific AI in Cancer Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Siemens Healthineers AG
16.3.2. GE HealthCare Technologies Inc
16.3.3. Koninklijke Philips N.V.
16.3.4. Fujifilm Holdings Corporation
16.3.5. International Business Machines Corporation
16.3.6. Roche Diagnostics International AG
16.3.7. Thermo Fisher Scientific Inc.
16.3.8. QIAGEN N.V.
16.3.9. Agilent Technologies, Inc.
16.3.10. Hologic, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AI IN CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AI IN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. AI IN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. AI IN CANCER DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. AI IN CANCER DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. AI IN CANCER DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. AI IN CANCER DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AI IN CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CT IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CT IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MRI IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MRI IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PET IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RADIOTHERAPY PLANNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RADIOTHERAPY PLANNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL PLANNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL PLANNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON PREMISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 157. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 160. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 161. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 162. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 163. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 164. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 165. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 166. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 167. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 168. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 169. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 170. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 171. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 172. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 173. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 174. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 175. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 178. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 179. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 184. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 185. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 186. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 187. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 192. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 193. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 194. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 195. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 196. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 197. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2024 (USD MILLION)
TABLE 306. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2025-2030 (USD MILLION)
TABLE 307. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2024 (USD MILLION)
TABLE 308. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2025-2030 (USD MILLION)
TABLE 309. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 310. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 311. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
TABLE 312. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2030 (USD MILLION)
TABLE 313. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2024 (USD MILLION)
TABLE 314. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2025-2030 (USD MILLION)
TABLE 315. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 316. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 317. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 318. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI in Cancer Diagnostics market report include:
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc
  • Koninklijke Philips N.V.
  • Fujifilm Holdings Corporation
  • International Business Machines Corporation
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Hologic, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 326.78 Million
Forecasted Market Value ( USD ) by 2030 $ 864.46 Million
Compound Annual Growth Rate21.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030 - Product Image

Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Brain Cancer Diagnostics Market by Technology (Genetic Testing, Imaging, Molecular Diagnostics), Product (Consumables & Reagents, Equipment, Services), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Breast Cancer Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Breast Cancer Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
Artificial Intelligence In Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Artificial Intelligence In Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Artificial Intelligence in Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Artificial Intelligence in Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.